Finance

Senarai
540222:BOM
Laurus Labs Ltd
₹2,036.00
-0.74%
(-15.10) 1H
14 Okt, 3:30:00 PTG GMT+5:30  ·   INR
Semua simbol
SimbolHargaPerubahan% Perubahan
Menjana cerapan popular untuk 540222...
Buka
₹2,051.95
Tinggi
₹2,051.95
Rendah
₹2,019.05
Permodalan Pasaran
1.10T
Purata volum
88.52K
Volum
43.56K
Dividen
0.10%
Dividen suku tahunan
₹0.50
Tarikh tanpa dividen
8 Mei 2026
Nisbah H/P
100.67
tgi 52 mgu
₹2,071.00
rdh 52 mgu
₹865.00
EPS
₹20.23
Syer tertunggak
106.44J
Bilangan pekerja
7K
Buka
₹2,051.95
Tinggi
₹2,051.95
Rendah
₹2,019.05
Permodalan Pasaran
1.10T
Purata volum
88.52K
Volum
43.56K
Dividen
0.10%
Dividen suku tahunan
₹0.50
Tarikh tanpa dividen
8 Mei 2026
Nisbah H/P
100.67
tgi 52 mgu
₹2,071.00
rdh 52 mgu
₹865.00
EPS
₹20.23
Syer tertunggak
106.44J
Bilangan pekerja
7K
Cerita berita
Daripada sumber web dan rakan kongsi berita
Profil
Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients, generic formulations, custom synthesis, biotechnology, veterinary APIs and agrochemicals. The company was founded in 2005 by Satyanarayana Chava. Laurus Labs has its eight manufacturing plants located at Visakhapatnam, Hyderabad and Bangalore. The manufacturing units have received one or more approvals from USFDA, WHO, NIP Hungary, KFDA, MHRA, TGA, and PMDA. The company operates through its subsidiaries in Europe and United States and also offers its services in contract research, clinical research and analytical research through its R&D centers. The R&D centres are based in Hyderabad, Visakhapatnam and United States. Wikipedia
Perihal Laurus Labs Ltd
CEOSatyanarayana Chava
Pekerja7.06K
Diasaskan2005
Ibu pejabat-
Sektor-
Laporan sebelumnyaSemua nilai dalam INR
Loading Previous Earnings...
Hasil
Pendapatan bersih
Semua nilai dalam INR
Sep 2025
Dis 2025
Mac 2026
Jun 2026
Hasil
16.53B
17.78B
18.12B
20.26B
Kos barangan yang dijual
6.63B
6.95B
8.34B
7.56B
Kos hasil
6.63B
6.95B
8.34B
7.56B
Perbelanjaan penyelidikan dan pembangunan
-
-
-
-
Jumlah perbelanjaan penyelidikan dan pembangunan
-
-
-
-
Perbelanjaan jualan, am dan pentadbiran
2.16B
2.29B
2.57B
2.59B
Belanja kendalian
7.07B
7.24B
5.86B
7.56B
Jumlah belanja kendalian
13.71B
14.19B
14.20B
15.12B
Pendapatan kendalian
2.83B
3.60B
3.92B
5.14B
Pendapatan bukan kendalian lain
269.60J
57.60J
-330.90J
91.80J
EBT termasuk item luar biasa
2.70B
3.25B
3.62B
4.81B
EBT tidak termasuk item luar biasa
2.70B
3.25B
3.62B
4.81B
Belanja cukai pendapatan
759.80J
734.50J
794.60J
1.19B
Kadar cukai berkesan
28.09%
22.58%
21.98%
24.79%
Belanja kendalian lain
3.71B
3.74B
2.07B
3.73B
Pendapatan bersih
1.95B
2.52B
2.79B
3.68B
Margin untung bersih
11.79%
14.15%
15.41%
18.14%
Perolehan bagi setiap syer
3.61
4.65
5.17
6.80
Pendapatan faedah dan pelaburan
-
-
65.70J
-
Belanja faedah
-400.00J
-387.90J
-307.60J
-422.20J
Belanja faedah bersih
-400.00J
-387.90J
-241.90J
-422.20J
Caj susut nilai dan pelunasan
1.20B
1.21B
1.22B
1.24B
EBITDA
4.01B
4.62B
5.12B
6.34B
Keuntungan atau kerugian daripada jualan aset
-
-
-
-
Kandungan AI boleh mengandungi kesilapan. Ketahui lebih lanjut
BantuanHantar maklum balasPrivasiSyaratPenafian
Apl Google